Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Dr Garber Talks About Michael Jackson and Chemically Induced Sleep
  • USA - English


News provided by

Dr. Garber's Natural Solutions

Aug 04, 2013, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Dr. Stuart H. Garber, DC, PhD
Dr. Stuart H. Garber, DC, PhD

Santa Monica, CA (PRWEB) August 04, 2013 -- Natural Sleep is necessary to life. Each night it rejuvenates and re-energizes one's body, keeping it running at its maximum potential.

New findings in the Michael Jackson wrongful death suit revealed that Dr. Conrad Murray was treating Jackson’s insomnia with Propofol on a daily basis, placing him into a catatonic state. However, a drug-induced coma does not offer the same reparative qualities provided by a true night’s sleep.

It’s not only about the number of hours one sleeps,” explains Dr. Garber, “it’s also about the type of sleep one gets.

Post this

According to the Associated Press on June 21, 2013 http://bigstory.ap.org/article/expert-michael-jackson-was-totally-sleep-deprived, sleep expert Charles Czeisler, who gave testimony in the case, cited reports that the entertainer was not only losing weight and exhibiting signs of paranoia, but his overall condition appeared to be deteriorating. These symptoms were consistent with someone who hadn't gotten any real sleep in a long time.

Insomnia is a common ailment, affecting people from all walks of life. According to the Center for Disease Control and Prevention, “An estimated 50-70 million US adults have sleep or wakefulness disorder.”

Dr. Stuart H. Garber explains the importance of natural sleep in this article posted on his website. He joins the platform of sleep reform that is proposed by media titans Dr. Oz and Arianna Huffington.

Ms. Huffington, a sleep advocate, has written numerous articles about the benefits of sleep in our everyday lives. In several of her articles, Huffington suggests that the lack of sleep can cause accidents, poor decisions, and more; conversely, receiving a full night’s rest can reduce stress and help to create success in our daily lives.

Like a mirage in the desert, many yearn for the elusive seven-eight hours of sleep and have become addicted to prescription sleep aids. These habit-forming routines create a vicious cycle. Once the body becomes accustomed to the drug, a stronger dosage is needed to fall asleep. In light of recent accidental deaths of prescription drug users in the news, the general public is now choosing to seek out natural alternatives. Holistic options have increasingly become available, but the consumer must investigate these products as well.

Dr. Stuart H. Garber was the first person in the United States to receive a Ph.D. degree in homeopathy and has been practicing holistic medicine since 1981. Dr. Garber stresses the necessity of getting a full, restful sleep. “It’s not only about the number of hours one sleeps,” explains Dr. Garber, “it’s also about the type of sleep one gets. Sleep occurs in various stages of REM (rapid eye movement) and non-REM sleep, which are differentiated by which type of brain wave predominates. If we don’t get into the non-REM part of the sleep cycle which results in deep restful sleep, we can’t obtain the full rejuvenating benefit that sleep is supposed to provide.”

When asked to comment on the Michael Jackson issue, Garber continues, “Propofol is just an extreme example. It’s not even indicated for use as a sleep aid although all of the most commonly prescribed sleep drugs act on our brain chemistry in much the same manner as Propofol. The popular sleep drug Ambien, as well as drugs like Valium and Xanax, produce sedative effects by affecting the action of a certain brain chemical (the neurotransmitter GABA) which seemingly helps people sleep yet prevents deep sleep. Aside from this single most important problem with these drugs, the list of their side effects (sleep driving and sleep eating among them) is long and serious.”

Dr. Garber practices in Santa Monica, CA and serves as president of the California Homeopathic Medical Society. He created Dr. Garber's Natural Solutions®, a unique line of biotherapy formulas that safely and effectively address many of the most common conditions while producing no harmful side effects. Recommended by doctors to their patients for over 10 years nationwide, the sleep remedy is the number one selling remedy in the product line.

Dr. Garber has lectured to the general public and has also addressed medical, dental, chiropractic, and acupuncture groups in the United States, Europe, Asia, and the Caribbean. He offers advice on health issues for the Huffington Post.

Kathy Leonardo, Dr. Garber's Natural Solutions, http://www.drgarbers.com, 310-344-7883, [email protected]

Modal title

Dr. Garber's Natural Solution for Sleep
Dr. Garber's Natural Solution for Sleep
Dr. Garber's Natural Solution for Sleep

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.